Results 1 to 10 of about 51,588 (239)
Seizures Associated With Bone Density Conservation Agents. [PDF]
J Pharm Technol, 2022 Objective The purpose of this review is to discuss the existing literature regarding patients who have experienced seizures after administration of a bone density conservation agent (BDCA). Data Sources A comprehensive literature review was performed between September and October 2021 using the following keywords: osteoporosis/drug therapy, seizures ...
Sturgill K, Reinert JP.
europepmc +3 more sources
Therapeutic Drug Review on Romosozumab: The First Sclerostin Inhibitor [PDF]
Journal of Clinical and Diagnostic Research, 2022 Osteoporosis is a progressive skeletal disorder which is characterised by low bone mass, normal mineralisation and abnormal bone microarchitecture. This disruption of bone microarchitecture causes subsequent increase in bone fragility and raises risk of ...
Vijay Kumar Jain +3 more
doaj +1 more source
When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
Frontiers in Endocrinology, 2021 Glucocorticoid-induced osteoporosis (GIOP) leads to fractures in up to 40% of patients with chronic glucocorticoid (GC) therapy when left untreated. GCs rapidly increase fracture risk, and thus many patients with anticipated chronic GC exposures should ...
Kaleen N. Hayes +5 more
doaj +1 more source
Transplantation Reports, 2022 Background: Osteoporosis is a prevalent complication in heart transplant population. Denosumab is a monoclonal antibody that inhibits bone resorption approved for the treatment of corticosteroid-induced osteoporosis and potentially useful in heart ...
Juan C. Uzquiano +5 more
doaj +1 more source
Journal of Bone Oncology, 2022 Background: Giant-cell tumor of bone (GCTB) is a relatively benign, but locally aggressive osteoclastogenic stromal tumour of the bone. Although denosumab has been approved as an monoclonal antibody against RANK ligand for the treatment of GCTB, few ...
Jiaji Yue, Wei Sun, Shenglong Li
doaj +1 more source
Dental Evaluation Prior to Cancer Therapy
Frontiers in Oral Health, 2022 A comprehensive oral examination and dental care prior to the start of cancer therapy is the standard of care in many cancer centers. This is because good oral health will likely minimize the undesirable complications such as opportunistic infections ...
Chee Weng Yong +2 more
doaj +1 more source
Acta Stomatologica Croatica, 2023 Antiresorptive drugs (AR) have been used for many years in the treatment of various bone conditions such as osteoporosis, osteopenia, Paget’s disease, bone metastases, multiple myeloma and the associated malignant hypercalcemia.
Sven Bival +5 more
doaj +1 more source
Vitamin C Prevents Hypogonadal Bone Loss [PDF]
, 2012 Epidemiologic studies correlate low vitamin C intake with bone loss. The genetic deletion of enzymes involved in de novo vitamin C synthesis in mice, likewise, causes severe osteoporosis. However, very few studies have evaluated a protective role of this
Brenda Smith +15 more
core +7 more sources
Use of natural resins in repairing damaged timber beams – An experimental investigation [PDF]
, 2019 Different techniques including the application of steel elements, composite materials and polymeric resins have been used in the past to repair damaged timber beams.
Benedetti, G +3 more
core +3 more sources
Nanoroughness, Surface Chemistry and Drug Delivery Control by Atmospheric Plasma Jet on Implantable Devices [PDF]
, 2018 Implantable devices need specific tailored surface morphologies and chemistries to interact with the living systems or to actively induce a biological response also by the release of drugs or proteins.
Ambrosi, Emmanuele +8 more
core +3 more sources